annual EBITDA:
-$390.12M+$43.18M(+9.97%)Summary
- As of today (September 15, 2025), GH annual EBITDA is -$390.12 million, with the most recent change of +$43.18 million (+9.97%) on December 31, 2024.
- During the last 3 years, GH annual EBITDA has fallen by -$30.50 million (-8.48%).
- GH annual EBITDA is now -889.60% below its all-time high of -$39.42 million, reached on December 31, 2016.
Performance
GH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$96.41M+$4.39M(+4.36%)Summary
- As of today (September 15, 2025), GH quarterly EBITDA is -$96.41 million, with the most recent change of +$4.39 million (+4.36%) on June 30, 2025.
- Over the past year, GH quarterly EBITDA has dropped by -$6.50 million (-7.22%).
- GH quarterly EBITDA is now -695.62% below its all-time high of -$12.12 million, reached on March 31, 2018.
Performance
GH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$419.46M-$6.50M(-1.57%)Summary
- As of today (September 15, 2025), GH TTM EBITDA is -$419.46 million, with the most recent change of -$6.50 million (-1.57%) on June 30, 2025.
- Over the past year, GH TTM EBITDA has increased by +$47.75 million (+10.22%).
- GH TTM EBITDA is now -1456.54% below its all-time high of -$26.95 million, reached on September 30, 2017.
Performance
GH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | -7.2% | +10.2% |
| 3 y3 years | -8.5% | +20.5% | +2.2% |
| 5 y5 years | -582.9% | -97.1% | -302.6% |
GH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.5% | +36.6% | -8.4% | +48.3% | -4.6% | +19.3% |
| 5 y | 5-year | -582.9% | +36.6% | -97.1% | +48.3% | -302.6% | +19.3% |
| alltime | all time | -889.6% | +36.6% | -695.6% | +48.3% | -1456.5% | +19.3% |
GH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$96.41M(-4.4%) | -$419.46M(+1.6%) |
| Mar 2025 | - | -$100.81M(-12.7%) | -$412.96M(+3.0%) |
| Dec 2024 | -$390.12M(-10.0%) | -$115.51M(+8.2%) | -$401.13M(-15.0%) |
| Sep 2024 | - | -$106.73M(+18.7%) | -$471.93M(+1.0%) |
| Jun 2024 | - | -$89.92M(+1.1%) | -$467.21M(-3.8%) |
| Mar 2024 | - | -$88.97M(-52.2%) | -$485.77M(-6.6%) |
| Dec 2023 | -$433.31M(-29.5%) | -$186.31M(+82.6%) | -$519.91M(+11.4%) |
| Sep 2023 | - | -$102.01M(-6.0%) | -$466.86M(-6.5%) |
| Jun 2023 | - | -$108.48M(-11.9%) | -$499.25M(-2.5%) |
| Mar 2023 | - | -$123.11M(-7.6%) | -$512.10M(+1.8%) |
| Dec 2022 | -$614.91M(+71.0%) | -$133.26M(-0.8%) | -$503.03M(+9.0%) |
| Sep 2022 | - | -$134.39M(+10.8%) | -$461.35M(+7.6%) |
| Jun 2022 | - | -$121.34M(+6.4%) | -$428.74M(+7.3%) |
| Mar 2022 | - | -$114.04M(+24.5%) | -$399.45M(+2.9%) |
| Dec 2021 | -$359.62M | -$91.58M(-10.0%) | -$388.27M(+1.3%) |
| Sep 2021 | - | -$101.79M(+10.6%) | -$383.25M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$92.04M(-10.5%) | -$351.36M(+14.0%) |
| Mar 2021 | - | -$102.85M(+18.8%) | -$308.24M(+36.5%) |
| Dec 2020 | -$225.07M(+294.0%) | -$86.56M(+23.8%) | -$225.80M(+41.5%) |
| Sep 2020 | - | -$69.90M(+42.9%) | -$159.55M(+53.2%) |
| Jun 2020 | - | -$48.92M(+139.7%) | -$104.18M(+53.5%) |
| Mar 2020 | - | -$20.41M(+0.5%) | -$67.86M(-1.3%) |
| Dec 2019 | -$57.13M(-24.7%) | -$20.32M(+39.9%) | -$68.76M(-6.7%) |
| Sep 2019 | - | -$14.53M(+15.2%) | -$73.66M(-9.4%) |
| Jun 2019 | - | -$12.61M(-40.8%) | -$81.34M(-8.1%) |
| Mar 2019 | - | -$21.31M(-15.5%) | -$88.48M(+11.6%) |
| Dec 2018 | -$75.84M(+0.7%) | -$25.22M(+13.6%) | -$79.29M(+17.6%) |
| Sep 2018 | - | -$22.20M(+12.4%) | -$67.43M(-6.6%) |
| Jun 2018 | - | -$19.75M(+63.0%) | -$72.17M(+37.7%) |
| Mar 2018 | - | -$12.12M(-9.3%) | -$52.42M(+30.1%) |
| Dec 2017 | -$75.31M(+91.0%) | -$13.36M(-50.4%) | -$40.30M(+49.6%) |
| Sep 2017 | - | -$26.95M | -$26.95M |
| Dec 2016 | -$39.42M | - | - |
FAQ
- What is Guardant Health, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Guardant Health, Inc.?
- What is Guardant Health, Inc. annual EBITDA year-on-year change?
- What is Guardant Health, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Guardant Health, Inc.?
- What is Guardant Health, Inc. quarterly EBITDA year-on-year change?
- What is Guardant Health, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Guardant Health, Inc.?
- What is Guardant Health, Inc. TTM EBITDA year-on-year change?
What is Guardant Health, Inc. annual EBITDA?
The current annual EBITDA of GH is -$390.12M
What is the all time high annual EBITDA for Guardant Health, Inc.?
Guardant Health, Inc. all-time high annual EBITDA is -$39.42M
What is Guardant Health, Inc. annual EBITDA year-on-year change?
Over the past year, GH annual EBITDA has changed by +$43.18M (+9.97%)
What is Guardant Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of GH is -$96.41M
What is the all time high quarterly EBITDA for Guardant Health, Inc.?
Guardant Health, Inc. all-time high quarterly EBITDA is -$12.12M
What is Guardant Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, GH quarterly EBITDA has changed by -$6.50M (-7.22%)
What is Guardant Health, Inc. TTM EBITDA?
The current TTM EBITDA of GH is -$419.46M
What is the all time high TTM EBITDA for Guardant Health, Inc.?
Guardant Health, Inc. all-time high TTM EBITDA is -$26.95M
What is Guardant Health, Inc. TTM EBITDA year-on-year change?
Over the past year, GH TTM EBITDA has changed by +$47.75M (+10.22%)